A composition comprising water and a polyalkylene glycol having an allyl content of less than 20 ueq/g, which composition has reduced foaming properties and preferably a biodegradability of at least 60% as determined using OECD 301F. The polyalkylene glycol can be made by forming a first intermediate comprising an oxypropylene block by reacting propylene oxide with a polyol initiator in the presence of a Double Metal Cyanide catalyst, and then reacting the first intermediate with ethylene oxide in the presence of a KOH catalyst.

Phosphate-containing copolymers, medical compositions containing the phosphate-containing copolymers, and methods of suppressing microbial virulence are provided. By suppressing virulence, administration and/or application of the medical compositions can be used to prevent, mitigate, or treat a microbial infection. The phosphate-containing copolymers are prepared by phosphorylating either a random copolymer or a random copolymeric block that contains monomeric units of propylene oxide and glycidol.

A vesicle incorporate a transmembrane protein, the vesicle forming material including a mixture of poly(ethylene glycol)-block-poly(propylene glycol)-block-poly(ethylene glycol) and polyetheramine. The vesicle can generally withstand elevated temperature without substantial shrinkage of the diameter, which in turn results in maintenance of the water permeability virtually unaffected. Pluronic based vesicles have a large content of amino groups available on the surface illustrated by the larger zeta potential values available for crosslinking in the polyamide layer by chemical reaction with trimesoyl chloride (TMC).

The present invention relates to an agrochemical aqueous suspension concentrate comprising a pesticide in the form of pesticide particles and at least 5 wt % of an adjuvant dissolved in the aqueous phase, wherein the adjuvant is of the formula (I) as defined herein. The invention also relates to the adjuvant as defined in formula (I). Furthermore, the invention relates to a process for the preparation of the suspension concentrate by contacting water, the pesticide, and the adjuvant. The present invention further relates to a method of controlling phytopathogenic fungi and/or undesired plant growth and/or undesired insect or mite attack and/or for regulating the growth of plants.

The present invention relates to curable resin compositions, to methods for producing a cured composition using said curable resin compositions, and articles, in particular molded parts, produced by such methods.

A cleaned biobased polyoxyalkylene glycol polyol, wherein the cleaned biobased polyoxyalkylene glycol polyol is completely primary hydroxyl-tipped or end-grouped, further wherein the cleaned biobased polyoxyalkylene glycol polyol comprises less than 15 ppm sodium and potassium metals, and further wherein the cleaned biobased polyoxyalkylene glycol polyol comprises less than 0.5% water by weight.

This invention relates to an in-situ formed polyol blend having an overall functionality of 2 to 3 and an overall hydroxyl number of 50 to 150. A process for preparing these polyol blends is also disclosed. These in-situ formed polyol blends are suitable for preparing viscoelastic flexible polyurethane foams. A process for preparing these foams is also disclosed.

An alkylene oxide derivative represented by formula (1), wherein a ratio Mz/Mw of a weight average molecular weight (Mw) and z average molecular weight (Mz) calculated from a chromatogram obtained by gel permeation chromatography measurement of the alkylene oxide derivative satisfies formula (2) below:

[00001]$\begin{array}{cc}{Z-\left[O-{\left(PO\right)}_a-{\left(PO\right)}_b/\left(EO\right)c\right]-H]}_n& \left(1\right)\\ 5\leqq M_z/M_w\leqq 60& \left(2\right)\end{array}$

where Z, n, PO, EO, a, b and c are as defined herein; a+b+c≥10, and b/c=1/5˜5/1; (PO).sub.b/(EO).sub.c indicates that PO and EO are randomly added; and a random ratio x of PO and EO satisfies 0.1≤x≤1.

A cleaned biobased polyoxyalkylene glycol polyol with an oxyethylene content of at least 40 mole percent, constituting 31.80 to 67.95 percent biogenic carbon content by weight, having less than 15 ppm combined sodium and potassium metals, and having less than 0.5 percent water by weight.

Enema compositions containing corticosteroids or salicylic acid derivatives are disclosed. The compositions are liquid at room temperature but turn to gels at body temperature. They are useful for treating inflammatory bowel disease.